Artiva Biotherapeutics, Inc.

ARTV · Healthcare · Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for pa…

Artiva Biotherapeutics, Inc. (ARTV), in the Healthcare sector, has 17 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 10 purchases and 7 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 3. The most active filer was Ra Capital Management, L.P. with 9 filings. Data as of Nov 7 2026.

Add to watchlist

Filings, ttm

10 buys · 7 sells · 1 late

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$111.1M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Nov 2

Filed Nov 3

ADViAverage daily dollar volume

$6.3M

market data

Share price · 12M

$4.15 (+13.4%)

Adjusted for splits and dividends.

Volume by month

Buys $109.0M Sells $2.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

RP Ra Capital Management, L.P. Director 9 filings · 9 buys, 0 sales FA

Fred Aslan President and CEO 7 filings · 0 buys, 7 sales GC GC Corp. 10% owner 1 filing · 1 buy, 0 sales CH

Christopher Horan Chief Tech Operations Officer 1 filing · 0 buys, 1 sale

Recent filings

Fred AslanSALE Chief Executive Officer $260K
62,178 sh × $4.18
Exec Nov 2
Filed Nov 3 · 4:04 PM ET Fred AslanSALE Chief Executive Officer $169K
23,463 sh × $7.20
Exec Oct 6
Filed Oct 7 · 4:02 PM ET Fred AslanSALE Chief Executive Officer $422K
61,696 sh × $6.84
Exec Oct 5
Filed Oct 6 · 4:01 PM ET Fred AslanSALE Chief Executive Officer $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET Christopher HoranSALE Chief Tech Operations Officer $116K
10,366 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:04 PM ET Fred AslanSALE Chief Executive Officer $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET Ra Capital Management, L.P.PURCHASE Director $456K
45,768 sh across 2 lots
Exec Jul 29
Filed Jul 31 · 5:13 PM ET Ra Capital Management, L.P.PURCHASE Director $413K
41,319 sh × $9.99
Exec Jul 24
Filed Jul 28 · 5:24 PM ET Ra Capital Management, L.P.PURCHASE Director $2.6M
264,586 sh across 3 lots
Exec Jul 21
Filed Jul 23 · 9:22 PM ET Ra Capital Management, L.P.PURCHASE Director $1.4M
152,472 sh × $8.93
Exec Jul 16
Filed Jul 20 · 6:08 PM ET Ra Capital Management, L.P.PURCHASE Director $135K
15,102 sh × $8.97
Exec Jul 10
Filed Jul 14 · 7:00 PM ET Ra Capital Management, L.P.PURCHASE Director $275K
31,000 sh × $8.88
Exec Jun 25
Filed Jun 29 · 4:20 PM ET Ra Capital Management, L.P.PURCHASE Director $4.6M
531,326 sh across 3 lots
Exec Jun 12
Filed Jun 16 · 6:08 PM ET Ra Capital Management, L.P.PURCHASE Director $7.6M
1,027,619 sh across 2 lots
Exec Jun 9
Filed Jun 11 · 7:36 PM ET GC Corp.PURCHASE 10% owner $16.5M
1,432,291 sh across 2 lots
Exec May 11
Filed May 28 · 4:34 PM ET † Fred AslanSALE Chief Executive Officer $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET Ra Capital Management, L.P.PURCHASE Director $75.0M
6,510,416 sh × $11.52
Exec May 11
Filed May 13 · 5:45 PM ET Fred AslanSALE President and CEO $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET